Today: March 24, 2018, 10:48 am

Market Dynamics to Escalate Demand for Dengue Vaccine Market Throughout 2017 - 2027

Dengue Vaccine Market
Dengue Vaccine Market
Future Market Insights has announced the addition of the “Dengue Vaccine Market : Global Industry Analysis and Opportunity Assessment, 2017-2027"report to their offering. 2017-11-14 14:06:28
Burdening occurrence of dengue fever across the Asia-Pacific region has prompted the demand for effective vaccines and medications to supress this viral malaise. While several pharmaceutical companies are striving to develop a cure for dengue, the fever’s incidence rate in Asia-Pacific is rising at an alarming rate. A recent report published by Future Market Insights predicts that in 2017, an estimated 70.3% of global dengue vaccines market will be dominated by Asia-Pacific. Through 2027, the region will continue to be the largest market for dengue vaccines, procuring a majority revenue share and projecting revenue growth at a 17.4% CAGR.

Future Market Insights also observes Latin America as the second-largest market for dengue vaccines, and is expected to rake in US$ 288.7 Mn towards the end of 2027. The report, titled “Dengue Vaccines Market: Global Industry Analysis and Opportunity Assessment, 2017-2027,” expects that more and more pharmaceutical giants from across the globe will be partaking in the market’s growth in the years to come. Currently, the market is witnessing active participation of French drugmaker, Sanofi S.A., while vaccines being formulated by companies such as Biological E. Limited, Takeda Pharmaceutical Company Limited, GlaxoSmithKline plc, Merck & Co. Inc., Vabiotech, Butantan Institute, and Panacea Biotech Ltd. are under multiple phases of development.

Request to View Sample Report @

The report further reveals that government institutes will remain the largest end-users of dengue vaccines in the world. Through 2027, a little less than US$ 650 Mn worth of revenues is expected to arise from sales of dengue vaccines across government institutes. Meanwhile, hospitals will also dominate the market by registering a 17.3% revenue CAGR. The market, at present, will witness sales of the sole of vaccine, Dengvaxia, developed by Sanofi. Furthermore, factors shaping up the dynamics of global dengue vaccines market, also compiled in the report, are: Apart from the burdening outbreak of dengue in several countries, the economic turmoil in Latin America is projected to impact the global market’s growth at a macroeconomic level

Request For Table Of Content @

Live attenuated vaccines are being developed & produced economically, thereby comforting vaccine makers as well as patients

However, lack of skilled professionals and unavailability of optimum diagnostic systems has given rise to cases where dengue fever is being treated as an undistinguished febrile disease

The global market for dengue vaccines holds an opportunistic breakthrough when drugmakers will be able to successfully develop effective vaccines for all age group

Buy Dengue Vaccine Market Research Report @

Press Information
future market insights
616 Corporate Way, Suite 2-9018, Valley Cottage,NY


Published by
Abhishek Budholiya

# 444 Words
Related Articles
More From The Author
Market Insights on Growth of Smart Insulin [..]
Increasing pool of diabetic patients witnessed across the globe has prompted leading manufacturers of medical devices towards development [..]
Growth Prospects of Global Aircraft Refurbishing Market [..]
Future Market Insights’ recently published report on global market for aircraft refurbishing projects that during a forecast period [..]
Growth Prospects of Global Automotive Wheel Coating [..]
Economic crisis observed in multiple parts of the world is being cited as a key restraint for sales of automotive [..]
Growth Prospects of Varicose Vein Treatment Market [..]
Varicose Vein Treatment Market Registering a Robust growth at 6.4% CAGR Through 2016-2026 Future Market Insights recently conducted [..]
Discover the Growth of the Atrophic Gastritis [..]
Atopic gastritis is chronic inflammation of gastric mucosa, and it is a histopathological condition associated with gastric glandular [..]
More From Business
03/23/2018Webcast Conference Call Scheduled for 8 a.m. CDT  MILWAUKEE, March 23, 2018 - Harley-Davidson, Inc. (NYSE:HOG) will [..]
Nasdaq Welcomes Dropbox, Inc. (Nasdaq: DBX) to [..]
NEW YORK, March 23, 2018 (GLOBE NEWSWIRE) -- Dropbox, Inc. (Nasdaq:DBX), a leading global collaboration platform, visited the [..]
FERRATUM OYJ: Managers' Transactions
Ferratum Oyj - Managers' Transactions ____________________________________________   Person subject to the notification requirement [..]
Cramo Plc: Managers' transactions
Cramo Plc  Stock Exchange Release  23 March 2018 at 6.45 pm (EET) Notification of Managers' transactions Cramo Plc - [..]
REC Silicon ASA - Successfully completed bond [..]
REC Silicon ASA has successfully completed a USD 110 million senior secured bond issue with maturity date 13th April 2023. [..]

Disclaimer: If you have any questions regarding information in this press release please contact the company added in the press release. Please do not contact pr-inside. We will not be able to assist you. PR-inside disclaims the content included in this release.